ZFYVE19
Basic information
Region (hg38): 15:40807086-40815084
Links
Phenotypes
GenCC
Source:
- cholestasis, progressive familial intrahepatic, 9 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cholestasis, progressive familial intrahepatic, 9 | AR | Gastrointestinal | The condition involves sequelae of cholestasis, and medical management (with ursodeoxycholic acid) has been described as beneficial; Liver transplant has been described | Gastrointestinal | 32737136; 33853651 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZFYVE19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 33 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 13 | |||||
Total | 0 | 1 | 35 | 11 | 0 |
Variants in ZFYVE19
This is a list of pathogenic ClinVar variants found in the ZFYVE19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-40807356-C-A | Likely benign (May 27, 2022) | |||
15-40807361-G-A | Likely benign (May 15, 2023) | |||
15-40807371-C-G | not specified | Uncertain significance (Nov 06, 2023) | ||
15-40807379-G-T | Uncertain significance (Aug 16, 2022) | |||
15-40807379-GC-TT | Uncertain significance (Jun 29, 2023) | |||
15-40807388-T-G | Uncertain significance (Oct 04, 2022) | |||
15-40807393-A-C | Uncertain significance (Feb 20, 2022) | |||
15-40807398-C-T | Uncertain significance (Nov 23, 2022) | |||
15-40807402-C-T | Likely benign (May 22, 2023) | |||
15-40807404-G-A | Likely benign (Aug 24, 2022) | |||
15-40807424-A-G | Uncertain significance (Nov 29, 2022) | |||
15-40807429-C-G | Uncertain significance (Oct 04, 2022) | |||
15-40807430-T-G | Uncertain significance (Jan 11, 2022) | |||
15-40807599-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
15-40807615-C-G | not specified | Uncertain significance (Jul 30, 2023) | ||
15-40807696-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
15-40807714-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
15-40807728-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
15-40807792-A-T | not specified | Uncertain significance (Aug 16, 2021) | ||
15-40807815-A-G | Cholestasis, progressive familial intrahepatic, 9 | Pathogenic (Apr 27, 2022) | ||
15-40807842-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
15-40809153-C-G | Cholestasis, progressive familial intrahepatic, 9 | Pathogenic (Apr 27, 2022) | ||
15-40809177-C-T | not specified | Likely benign (Apr 17, 2023) | ||
15-40809213-G-A | Cholestasis, progressive familial intrahepatic, 9 | Uncertain significance (Mar 25, 2024) | ||
15-40809218-C-T | Cholestasis, progressive familial intrahepatic, 9 | Pathogenic (Apr 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZFYVE19 | protein_coding | protein_coding | ENST00000355341 | 11 | 7484 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.20e-14 | 0.142 | 124740 | 0 | 84 | 124824 | 0.000337 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.445 | 251 | 272 | 0.924 | 0.0000153 | 2989 |
Missense in Polyphen | 62 | 73.807 | 0.84003 | 883 | ||
Synonymous | 0.135 | 102 | 104 | 0.983 | 0.00000546 | 943 |
Loss of Function | 0.942 | 24 | 29.5 | 0.813 | 0.00000171 | 281 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000386 | 0.000386 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00201 | 0.00200 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000239 | 0.000238 |
Middle Eastern | 0.00201 | 0.00200 |
South Asian | 0.000230 | 0.000229 |
Other | 0.000167 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission. {ECO:0000269|PubMed:24814515}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ZFYVE19 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with KMT2A/MLL1 (PubMed:12618766). {ECO:0000269|PubMed:12618766}.;
Intolerance Scores
- loftool
- 0.737
- rvis_EVS
- 1.62
- rvis_percentile_EVS
- 96.01
Haploinsufficiency Scores
- pHI
- 0.0323
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.425
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.465
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfyve19
- Phenotype
Gene ontology
- Biological process
- abscission;negative regulation of cytokinesis;mitotic cytokinesis checkpoint;cell division
- Cellular component
- cytoplasm;centrosome;midbody;cleavage furrow;Flemming body
- Molecular function
- protein binding;phosphatidylinositol-3-phosphate binding;metal ion binding